SenesTech, Inc.
General ticker "SNES" information:
- Sector: Materials
- Industry: Chemicals - Specialty
- Capitalization: $12.1M (TTM average)
SenesTech, Inc. does not follow the US Stock Market performance with the rate: -19.0%.
Estimated limits based on current volatility of 3.3%: low 0.82$, high 0.88$
Factors to consider:
- Total employees count: 23 (0.0%) as of 2025
- Top business risk factors: Commercialization failure, Sales infrastructure, Product liability and misuse, Regulatory and compliance, Manufacturing disruptions
- Current price 28.3% below estimated low
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.20$, 4.40$]
- 2026-12-31 to 2027-12-31 estimated range: [0.64$, 2.63$]
Financial Metrics affecting the SNES estimates:
- Positive: with PPE of -0.8 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: negative Operating cash flow
- Positive: Inventory ratio change, % of 0.59 <= 1.34
- Negative: negative Net income
- Positive: 69.38 < Shareholder equity ratio, % of 74.50 <= 81.92
- Positive: -2.60 < Investing cash flow per share per price, % of -1.48
- Positive: Interest expense per share per price, % of 0.03 <= 0.07
- Negative: -0.33 < Industry inventory ratio change (median), % of -0.11
- Positive: 0.59 < Industry operating profit margin (median), % of 1.52
- Positive: 2.08 < Industry earnings per price (median), % of 2.85
Short-term SNES quotes
Long-term SNES plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $1.19MM | $1.86MM | $2.22MM |
| Operating Expenses | $8.93MM | $8.11MM | $8.73MM |
| Operating Income | $-7.73MM | $-6.25MM | $-6.50MM |
| Non-Operating Income | $0.02MM | $0.07MM | $0.12MM |
| Interest Expense | $0.00MM | $0.02MM | $0.02MM |
| R&D Expense | $1.23MM | $1.71MM | $1.70MM |
| Income(Loss) | $-7.71MM | $-6.18MM | $-6.38MM |
| Net Income(Loss)* | $-7.71MM | $-6.18MM | $-6.38MM |
| Stockholders Equity | $6.35MM | $2.51MM | $9.57MM |
| Inventory | $0.80MM | $0.79MM | $0.99MM |
| Assets | $7.29MM | $3.28MM | $12.84MM |
| Operating Cash Flow | $-7.57MM | $-6.03MM | $-5.75MM |
| Capital expenditure | $0.15MM | $0.08MM | $0.14MM |
| Investing Cash Flow | $-0.15MM | $-0.06MM | $-1.10MM |
| Financing Cash Flow | $8.34MM | $2.00MM | $13.12MM |
| Earnings Per Share** | $-115.10 | $-8.86 | $-0.19 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.